We thrive on solving problems with our start-up founders. Over the years we've had the privilege of helping innovators evolve their ideas, disrupt markets, and chart strategic paths for continued growth. Here's just some of what we've learned along the way.
Q. Why did you decide to start Transcend Therapeutics? After learning of yet another friend’s suicide, I dedicated my career […]
There’s been a lot written lately about a slowdown in early stage tech funding by VC’s. At Emerald we don’t […]
Q. You were at Johns Hopkins University when you first conceived of Proscia. How did the idea come about? Proscia […]
Q. You spent the first half of your career in technology at major investment banks and financial institutions. What […]
Ian Tolfree, Ph.D., and Cy Schroeder Each Named Principal, Joshua Smith Appointed Director, Investor Relations New York and Miami, November […]
Q. Evolved By Nature describes itself as a new type of biotech company. Can you explain what that means and […]
New York and Miami, June 16, 2022 – Emerald Development Managers today announced that Abbe Serphos has been appointed Operating […]
Reports detail the potential 2022 market opportunity for Clean Tech to be $2.5 trillion, with significant additional growth anticipated by 2030. Why? And why now?